Stéphanie Mereniuk Kappel Dias

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Approximately 35% of patients with confirmed HER2 breast cancer progress to metastases of the central nervous system (CNS). Total cerebral radiotherapy is considered as standard treatment for these cases; however, studies have shown that some chemotherapy drugs can be used during radiotherapy without significantly increasing its toxicity. In this article,(More)
  • 1